Warsaw-based Zimmer Biomet Holdings Inc. (NYSE: ZBH) has announced a succession plan for retiring Executive Vice President and Chief Financial Officer Daniel Florin. The company has announced Suketu Upadhyay will succeed Florin, who will continue with the company in an advisory capacity.
President and Chief Executive Officer Bryan Hanson said, "Dan Florin has been my right hand since I joined Zimmer Biomet. He is an outstanding leader and has made significant contributions to Zimmer Biomet over his 12 years with the Company. As we have worked together tirelessly to reshape the organization over the last 18 months, I have been impressed by, and grateful for, his leadership, as well as his advice and counsel to me personally."
Upadhyay has more than two decades experience in corporate finance and accounting and currently serves as senior vice president, global financial operations at Bristol-Myers Squibb. He also held leadership positions at Becton Dickinson & Company as controller and interim chief financial officer, along with leadership roles at Johnso & Johnson and AstraZeneca.